Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qi-Shao-Tong-Mai-An-Shen Decoction is a Traditional Chinese Medicine (TCM) formula developed by the China-Japan Friendship Hospital specifically for the treatment of psycho-cardiological disorders, often referred to as "Double Heart Disease." This condition involves coronary heart disease (CHD) comorbid with psychological symptoms such as anxiety and depression. The decoction is formulated based on TCM principles to tonify Qi, nourish blood, promote blood circulation to unblock the meridians, and soothe the nerves to calm the mind. Its primary herbal components typically include *Astragalus membranaceus* (Huangqi) and *Paeonia lactiflora* (Baishao), which are combined with other herbs like *Salvia miltiorrhiza* and *Ziziphus jujuba* to address both the physical cardiovascular pathology and the associated emotional distress. Clinical studies suggest it improves cardiac function, reduces myocardial ischemia, and alleviates psychological symptoms by modulating the neuroendocrine-immune system and reducing systemic inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qi-Shao-Tong-Mai-An-Shen Decoction.